Xiamen Amoytop Biotech Co., Ltd. Class ASSE: 688278

Announcement on Approval of the Application for Market Authorization of Additional Indications for Peginterferon alfa-2b Injection

· Issued by Xiamen Amoytop Biotech Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Approval of the Application for Market Authorization of Additional Indications for Peginterferon alfa-2b Injection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment